Tamsulosin hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C20H28N2O5S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 11SV1951MR, chemically known as benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, monohydrochloride, (r)- but more generally known as tamsulosin hydrochloride, which bears US NIH Compound Identifier 5362376. European Medicines Agency schedules Tamsulosin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04673MIG. Most nations, for tariff and trade purposes, schedule tamsulosin hydrochloride under HS 29350090 and SITC 51580. As of Q4 2014, TAMSULOSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Tamsulosin hydrochloride bears US NLM identifiers UMLS ID C0771774 and NCI Concept Code C29486. SMILES: CCOC1CCCCC1OCCN[C@H](C)CC2CCC(C(C2)S(=O)(=O)N)OC.CL.